BSc(Med Sciences),
MBChB(Bachelor of Medicine & Surgery)
MSCE(Master of Clinical Epidemiology)
Global health and leadership fellowship
Dr. Molefi is a senior Lecturer and Epidemiologist in the Department of Family Medicine and Public Health at the Faculty of Medicine, 4844³ÉÈËÃâ·Ñ¸£Àû. Dr Molefi’s teaching experience spans over five(5) years teaching at University. He teaches mainly principles of Epidemiology & Biostatistics to both undergraduates and postgraduates students. He is a seasoned scholar and adept at leading research initiatives. He has to date co-authored 18 research papers in reputable journals including Clinical Infectious Diseases journal and has been a reviewer for the likes of BMC, PLoS one etc.ÌýÌýHe trainedÌýwithÌýtheÌýAIDSÌýClinical TrialsÌýGroupÌý(ACTG) while atÌýtheÌýUniversityÌýofÌýPennsylvania and possesses further training in Clinical trials Ìýand translational researchÌý. He is also ÌýGlobal Health scholar with a wide research collaborationÌýnetwork( Botswana-UPenn Partnership-Botswana ,University of Pennsylvania Global Health-US, Fudan University-China,ÌýÌýSt. George's University-UK, Universities of Pretoria and Walter-Sisulu- South Africa etc. He is also an investigator ÌýforÌýthe D71 andÌýD43 training Ìýgrants .Dr. Molefi is also co-chair for the National Validation for the elimination of Mother-to-Child transmission of HIV and syphilis.ÌýÌý
Principles of Epidemiology and biostatistics
Clinical Research MethodsÌý
Global health and leadership
Communicable diseasesÌý
Implementation Science
Health economics
Project planning & management
Ìý
Communicable disease(HIV and the related opportunistic infections)
Quasi-experimental methods for public health interventions
Evaluation of psychometric tools to complement clinical careÌý
Infectious Diseases Epidemiology(HIV, TB)
Chronic Diseases Epidemiology( Cancers)
Psychometric measurements tools( Health related quality of life measures)
Ìý
Ìý
Ìý
Ìý
- Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis
Ìý Ìý Ìý Ìý ÌýBisson GP, Molefi M et al. Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis. Clin Infect Dis. Ìý Ìý Ìý 2013 Oct;57(7):1067
- AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial
Ìý Ìý Ìý Ìý ÌýMolefi M, Chofle A, Molloy S et al.
Ìý Ìý Ìý Ìý Trials 2015, 16:276 (17 June 2015)
- Short Course High-dose Liposomal Amphotericin B for HIV-associated Cryptococcal Meningitis: A phase-II Randomized Controlled Trial
Ìý Ìý Ìý Ìý Ìý Jarvis JN, Leeme TB, Molefi M et al.
ÌýClin Infect Dis. 2019 Jan 18;68(3):393